Search
for

    Research 10 of 349

    1. 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization Journal of the American Academy of Dermatology · 2026
    2. Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in Modulating Preexisting Dermatologic Disease: A Systematic Review Cureus · 2025
    3. GLP‐1 agonists and hair loss: a call for further investigation International Journal of Dermatology · 2024
    4. GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects Frontiers in Endocrinology · 2021 · 59 citations
    5. Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study Cardiovascular Drugs and Therapy · 2024 · 25 citations
    6. Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons Dermatology and Therapy · 2025 · 1 citations
    7. The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes? American Journal of Clinical Dermatology · 2026
    8. Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia Skin Appendage Disorders · 2026
    9. Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review Cureus · 2025
    10. Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review Cureus · 2025
    All research results →

    Community 3

    1. Thoughts on this article? "Forget GLP-1 Stocks, Baldness Drugs Are Wall Street's Next Goldmine" Reddit · 17 Sept 2026
    2. Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here. Reddit · 19 Nov 2023
    3. Finally - Big Pharma now targeting hair-loss once again! Reddit · 22 Sept 2026

    Learn

    — no results

    Try a deeper search in learn →